SETRUSUMAB

UNII:	FPW3780T3E
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	SETRUSUMAB
GSRS Full Record:	FPW3780T3E i

1847394-95-9
BPS-804
BPS804
Immunoglobulin G2, anti-(human sclerostin) (human monoclonal BPS804 heavy chain), disulfide with human monoclonal BPS804 light chain, dimer
Immunoglobulin G2-lambda, anti-[Homo sapiens SOST (sclerostin)], Homo sapiens monoclonal antibody; gamma2 heavy chain (1-443) [Homo sapiens VH (IGHV3-66*01 (89.80%) -(IGHD) -IGHJ4*01) [8.8.10] (1-117) -IGHG2*01, G2m.. (CH1 (118-215), hinge (216-227), CH2 V45.1 (278) (228-336), CH3 (337-441), CHS (442-443)) (118-443)], (131-216')-disulfide with lambda light chain (1'-217’) [Homo sapiens V-LAMBDA (IGLV2-23*02 (92.60%) -IGLJ2*01) [9.3.11] (1'-111') -IGLC2*01 (112'-217')]; dimer (219-219'':220-220'':223-223'':226-226'')-tetrakisdisulfide
MOR-05813
MOR05813
SETRUSUMAB [USAN]
Setrusumab [WHO-DD]
UX-143
UX143
setrusumab [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

SETRUSUMAB

Synonyms and Mappings

Resources